Actuatetherapeuticsinc Nasdaqactuis A Clinical Stagebiopharmaceutical Company Focused On Developing Therapies For Thetreatment Of High Impactdifficult To Treat Cancersactuates Lead Investigational Drug Productelraglusiba Novel Gsk I Inhibitor Targets Molecular Pathways In Cancer That Areinvolved In Promoting Tumor Growth And Resistanceto Conventional Cancer Drugs Such As Chemotherapy Including Several Dna Damageresponseddrpathwayselraglusib Is Designed To Act As A Mediator Of Anti Tumor Immunity Through Theinhibition Of Nuclear Factor Kappa Light Chain Enhancer Of Activated B Cellsnf Kband Regulates Multipleimmunecheckpoints And Immunecell Functionfor Additional Informationpleasevisit Thecompany S Websiteat Http Www Actuatetherapeutics Com
